Optimization of antibodies examanination against thrombocytes in pregnant and postpartum women
Authors:
Z. Čermáková 1; P. Kovářová 2; A. Malušková 2; M. Paulišková 2; D. Fizková 2
Authors‘ workplace:
Lékařská fakulta Ostravské univerzity
1; Krevní centrum FN Ostrava, vedoucí pracoviště MUDr. Z. Čermáková, Ph. D.
2
Published in:
Ceska Gynekol 2011; 76(3): 239-242
Overview
Objective:
To optimize thrombocyte antibodies examination in pregnant and postpartum women.
Design:
Retrospective analysis.
Setting:
Blood Center, Faculty Hospital and Medical Faculty Ostrava University, Ostrava.
Methods:
Analysis and our experience with introducing the new test for thrombocyte antibodies examination.
Conclusion:
The thrombocyte antibodies examination that was introduce in the period 2008-2009 and is the combination of basic and special testing, seems to be optimal for the neonatal thrombocytopenia detection.
Key words:
thrombocyte antibodies, thrombocyte antigens, neonatal aloimmune thrombocytopenia.
Sources
1. Ahya, R., Turner, ML., Urbaniak, SJ., SNAIT Study Team. Fetomaternal alloimmune thrombocytopenia. Tranfus Apher Sci, 2001, 25, p. 139-145.
2. Bertrand, G., Martageix, C., Jallu, V., et al. Predictive value of sequential maternal anti-HPA-1a antibody concentrations for the sseverity of fetal alloimmune thrombocytopenia. J Thromb Haemost, 2006, 4, p. 628-637.
3. Blanchette, VS., Chen, L., de Friedberg, ZS. Alloimmunization to the PlA1 platelet antigen: results of a prospective study. Br J Haematol, 1990, 74, p. 209-215.
4. Blanchette, VS., Johnson, J., Rand, M. The management of alloimmune neonatal thrombocytopenia. Bailliére’s Best Pract Res Clin Haematol, 2000, 13, p. 365-390.
5. Davoren, A., Curtis, BR., Aster, RH., McFarland, JG. Human platelet antigen-specific alloantibodies implicated in 1162 cases of neonatal alloimmune thrombocytopenia. Transfusion, 2004, 44, p. 1220-1225.
6. Davoren, A., McFarland, JG., Crowley, J., et al. Antenatal screening for human platelet antigen-1a: result of a prospective study at a large maternity hospital in Ireland. Brit J Obstet Gynaec, 2003, 110, p. 492-496.
7. Dreyfus, M., Kaplan, C., Verdy, E. Frequency of immune thrombocytopenia in newborns: a prospective study. Immune Thrombocytopenia Working Group. Blood, 1997, 89, p. 4402-4406.
8. Durand-Zaleski, I., Schlegel, N., Blum-Boisgard, C. Screening primiparous women and newborns for fetal/neonatal alloimmune thrombocytopenia: a prospective comparison of effectiveness and costs. Immune Thrombocytopenia Working Group. Am J Perinatol, 1996, 13, p. 423-431.
9. Ghevaert, C., Campbell, K., Walton, J., et al. Management and outcome of 200 cases of fetomaternal alloimune thrombocytopenia. Transfusion, 2007, 47, p. 901-910.
10. Kiefel, V., Bassler, D., Kroll, H., et al. Antigen-positive platelet transfusion in neonatal alloimmune thrombocytopenia (NAIT). Blood, 2006, 107, p. 3761-3763.
11. Killie, MK., Husebekk, A., Kjeldsen-Kragh, J., Skogen, B. A prospective study of maternal anti-HPA 1a antibody level as a potential predictor of alloimmune thrombocytopenia in the newborn. Haematol, 93, 6, p. 870-877.
12. Koch, K., Stenzel, A., Bringman, G., et al. Neonatal alloimmune thrombocytopenia (NAIT) in twins caused by maternal HLA antibodies anti-HLA-A2 and anti-HLA-A68. Vox Sanguinis 2010, 99, Suppl. 1, p. 397.
13. Leach, MF., Aubuchon, JP. False reactivity in GTI Pak Plus ELISA kits due to the presence of anti-mouse antibody in patiens samples. Immunohematology 2003, 19, p. 112-116.
14. Mandelbaum, M., Koren, D., Eichelberger, L., et al. Frequencies of maternal platelet alloantibodies and autoantibodies in suspected fetal/neonatal alloimmune thrombocytopenia, with emphasis on human platelet antigen-15 alloimmunization. Vox Sang, 2005, 89, p. 39-43.
15. Mueller-Eckhardt, C., Kiefel, V., Grubert, A., et al. 348 cases of suspected neonatal alloimmune thrombocytopenia. Lancet, 1989, 1, p. 363-366.
16. Moncharmont, P., Dubois, V., Obegi, C., et al. HLA antibodies and neonatal alloimmune thrombocytopenia. Acta Haematol, 2004, 111, p. 215-220.
17. Munizza, M., Nance, S., Keashen-Schnell, MA., et al. Provosion of HPA-1a (PLA1)-negative platelets for neonatal alloimmune thrombocytopenia: screening, testing, and transfusion protocol. Immunohematology, 1999, 15, p. 71-74.
18. Porcelijn, L., van den Akker, ES., Oepkes, D. Fetal thrombocytopenia (Review). Semin Fetal Neonatal Med, 2008, 13, p. 223-230.
19. Saito, S., Ota, M., Komatsu, Y., et al. Serologic analysis of three cases of neonatal alloimmune thrombocytopenia associated with HLA antibodies. Transfusion, 2003, 43, p. 908-917.
20. von dem Borne, AE., Verheugt, FW., Oosterhof, F., et al. A simple immunofluorescence test for the detection of platelet antibodies. Br J Haematol, 1978, 39, p. 195-207.
21. Williamson, LM., Hacket, G., Rennie, J., et al. The natural history of fetomaternal alloimmunization to the platelet-specific antigen HPA-1a (PlA1, Zwa) as determined by antenatal screening. Blood, 1998, 92, p. 2280-2287.
22. Wu, GG., Kaplan, C., Curtis, BR., Pearson, HA. Report on the 14th international society of blood transfusion platelet immunology workshop. Vox Sanguinis, 2010, 99, p. 375-381.
Labels
Paediatric gynaecology Gynaecology and obstetrics Reproduction medicineArticle was published in
Czech Gynaecology
2011 Issue 3
Most read in this issue
- High resistance of bacterial strains Streptococcus agalactiae to antibiotic therapy in early-onset and late-onset disease in newborns
- Optimization of antibodies examanination against thrombocytes in pregnant and postpartum women
- Biophysical methods in diagnosis of intrapartal fetal hypoxia
- The role of hysterectomy in management of cervical precancer lesions